Recently published data show that GLP-1 promotes peripheral glucose utilisation5,6 but, more importantly, Nikolaidis et al.21 reported that infusion of GLP-1 as added therapy gave additional benefit to patients with acute myocardial infarction and severe systolic dysfunction after primary angioplasty. Here, GLP1R is linked to acute myocardial infarction.